References: Prevention of infection in patients with asplenia

Australian Commission on Safety and Quality in Health Care (ACSQHC). AURA 2021: Fourth Australian report on antimicrobial use and resistance in human health. Sydney: ACSQHC; 2021. https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system/aura-2021
Davies JM, Lewis MP, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PH, et al. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. Br J Haematol 2011;155(3):308-17. https://www.ncbi.nlm.nih.gov/pubmed/21988145
Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet 2011;378(9785):86-97. https://www.ncbi.nlm.nih.gov/pubmed/21474172
Kanhutu K, Jones P, Cheng AC, Grannell L, Best E, Spelman D. Spleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand. Intern Med J 2017;47(8):848-55. https://www.ncbi.nlm.nih.gov/pubmed/27925427
Rankine-Mullings AE, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev 2017;(10):CD003427. https://www.ncbi.nlm.nih.gov/pubmed/28994899
Rubin LG, Schaffner W. Clinical practice. Care of the asplenic patient. N Engl J Med 2014;371(4):349-56. https://www.ncbi.nlm.nih.gov/pubmed/25054718
Theilacker C, Ludewig K, Serr A, Schimpf J, Held J, Bogelein M, et al. Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study. Clin Infect Dis 2016;62(7):871-8. https://www.ncbi.nlm.nih.gov/pubmed/26703862